BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12631066)

  • 1. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Sivarajah A; Kvale EO; Dugo L; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Yaqoob MM; Thiemermann C
    Kidney Int; 2003 Mar; 63(3):853-65. PubMed ID: 12631066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Zacharowski K; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Oct; 62(4):1249-63. PubMed ID: 12234295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat.
    Chatterjee PK; Patel NS; Kvale EO; Brown PA; Stewart KN; Britti D; Cuzzocrea S; Mota-Filipe H; Thiemermann C
    Kidney Int; 2003 Nov; 64(5):1605-19. PubMed ID: 14531792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat.
    Chatterjee PK; Brown PA; Cuzzocrea S; Zacharowski K; Stewart KN; Mota-Filipe H; McDonald MC; Thiemermann C
    Kidney Int; 2001 Jun; 59(6):2073-83. PubMed ID: 11380809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
    Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis.
    Cuzzocrea S; Chatterjee PK; Mazzon E; McDonald MC; Dugo L; Di Paola R; Serraino I; Britti D; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2002 Oct; 453(1):119-29. PubMed ID: 12393067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
    Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
    Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats.
    Esposito E; Mondello S; Di Paola R; Mazzon E; Italiano D; Paterniti I; Mondello P; Aloisi C; Cuzzocrea S
    Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):493-508. PubMed ID: 21394482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney.
    Chatterjee PK; Patel NS; Kvale EO; Brown PA; Stewart KN; Mota-Filipe H; Sharpe MA; Di Paola R; Cuzzocrea S; Thiemermann C
    Am J Nephrol; 2004; 24(2):165-77. PubMed ID: 14752229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock.
    McDonald MC; Izumi M; Cuzzocrea S; Thiemermann C
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):555-69. PubMed ID: 12512692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury.
    Cuzzocrea S; Chatterjee PK; Mazzon E; Dugo L; De Sarro A; Van de Loo FA; Caputi AP; Thiemermann C
    Shock; 2002 Aug; 18(2):169-76. PubMed ID: 12166782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation.
    Dugo L; Marzocco S; Mazzon E; Di Paola R; Genovese T; Caputi AP; Cuzzocrea S
    Br J Pharmacol; 2004 Mar; 141(6):979-87. PubMed ID: 14769784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
    Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
    J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Mark LA; Robinson AV; Schulak JA
    J Surg Res; 2005 Dec; 129(2):236-41. PubMed ID: 16140334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury.
    Guven A; Uysal B; Akgul O; Cermik H; Gundogdu G; Surer I; Ozturk H; Korkmaz A
    Ren Fail; 2008; 30(7):747-54. PubMed ID: 18704824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.
    Chatterjee PK; Patel NS; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Eberhardt W; Pfeilschifter J; Thiemermann C
    Cardiovasc Res; 2004 Feb; 61(3):630-43. PubMed ID: 14962493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury.
    Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Mazzon E; Cuzzocrea S; Thiemermann C
    Biochem Pharmacol; 2005 Apr; 69(7):1121-31. PubMed ID: 15763548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury.
    Patel NS; Cortes U; Di Poala R; Mazzon E; Mota-Filipe H; Cuzzocrea S; Wang ZQ; Thiemermann C
    J Am Soc Nephrol; 2005 Mar; 16(3):712-9. PubMed ID: 15677308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo.
    Patel NS; Sharples EJ; Cuzzocrea S; Chatterjee PK; Britti D; Yaqoob MM; Thiemermann C
    Kidney Int; 2004 Sep; 66(3):983-9. PubMed ID: 15327391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.